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Transcriptional profiling is a useful strategy to study development
and disease. Approaches to isolate RNA from specific cell types, or
from specific cellular compartments, would extend the power of
this strategy. Previous work has shown that isolation of geneti-
cally tagged ribosomes (translating ribosome affinity purification;
TRAP) is an effective means to isolate ribosome-bound RNA
selectively from transgene-expressing cells. However, widespread
application of this technology has been limited by available trans-
genic mouse lines. Here we characterize a TRAP allele (Rosa26fsTRAP)
that makes this approach more widely accessible. We show that
endothelium-specific activation of Rosa26fsTRAP identifies endothe-
lial cell-enriched transcripts, and that cardiomyocyte-restricted TRAP
is a useful means to identify genes that are differentially expressed
in cardiomyocytes in a disease model. Furthermore, we show that
TRAP is an effective means for studying translational regulation,
and that several nuclear-encoded mitochondrial genes are under
strong translational control. Our analysis of ribosome-bound tran-
scripts also shows that a subset of long intergenic noncoding RNAs
are weakly ribosome-bound, but that the majority of noncoding
RNAs, including most long intergenic noncoding RNAs, are ribo-
some-bound to the same extent as coding transcripts. Together,
these data show that the TRAP strategy and the Rosa26fsTRAP
allele will be useful tools to probe cell type-specific transcrip-
tomes, study translational regulation, and probe ribosome binding
of noncoding RNAs.
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Genome-wide and unbiased measurement of RNA transcriptlevels using microarrays and RNA-seq (1) has powered
fundamental advances in biology over the past decade. However,
when used to study tissues composed of multiple cell types, RNA
expression profiling faces two fundamental limitations. First,
whole-tissue transcript levels represent the average of the dis-
tinct cell lineages in the tissue, and this averaging process can
result in loss of important information or misassignment of gene
expression changes in one type of cell to another. Second, RNA
profiling measures transcript abundance, but translational regu-
lation is also an important determinant of gene expression (2, 3).
To overcome these limitations, approaches have been de-
veloped to isolate RNAs from selected cell types and/or selected
transcript fractions (4–7). Often these approaches involve tissue
dissociation followed by FACS, but this is slow and the dissoci-
ation procedure itself likely alters expression profiles. Trans-
lating ribosome affinity purification (TRAP) permits isolation of
transcripts from selected cell types of intact tissues, without
dissociation (4). In this approach, ribosomes of selected tissues
are genetically labeled by transgenic expression of GFP fused to
L10a, an integral component of the 60S ribosomal subunit. To
collect RNA from the transgene-expressing subpopulation of
a tissue, whole-cell lysates are prepared under conditions that
stabilize ribosomes on RNA and block translation (Fig. 1A). Im-
munoprecipitation of GFP then selectively coprecipitates RNAs
from the target cell population. Moreover, the coprecipitated
RNAs (TRAP RNAs) are those actively engaged by ribosomes,
so that the method also enriches for RNAs that are “actively
translating.” Heiman et al. used this approach to profile actively
translating RNAs in rare cell populations in the central nervous
system (4). This study was based on tissue-selective expression of
GFP-L10a using BAC transgenes, so that each lineage of interest
required construction of a new transgenic mouse line.
Here we report generation of a mouse line in which lineage-
selective Cre activates expression of GFP-L10a. The resulting
mouse line permits selective isolation of ribosome-bound RNA
from Cre-marked cell lineages, and at the same time is useful as
a Cre-activated fluorescent reporter. In validation experiments,
we show that this mouse line in combination with endothelial-
selective Tie2-Cre (8) effectively isolates endothelial lineage-
selective genes, and we use this property to identify additional
putative endothelial-selective transcripts. In combination with
cardiomyocyte-selective cardiac troponin T (TNT)-Cre, we show
that cell type-specific transcriptional profiling is helpful to define
gene expression changes that occur in a specific cell type. Finally,
we use this unique tool to analyze ribosome binding to tran-
scripts. We show that ribosome binding to mitochondrial pro-
tein-coding transcripts is regulated in a tissue-specific manner,
with high ribosome binding occurring in heart and liver. For
noncoding transcripts, we show that a subset of long intergenic
noncoding RNAs (lincRNAs) display low ribosome binding,
consistent with their function in the absence of translation.
However, most noncoding transcripts, including the majority of
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lincRNAs, display ribosome binding comparable to that seen for
protein-coding transcripts. Collectively, these experiments in-
dicate that the Cre-activated TRAP allele will be a useful tool for
studying regulation of transcript ribosome binding and lineage-
specific gene expression.
Results
Rosa26fsTRAP Allele. Rpl10a encodes ribosomal protein L10a. Im-
munoprecipitation of GFP-tagged L10a using a GFP-specific
antibody selectively isolates transcripts from GFP-L10a–
expressing cells (Fig. 1A) (4). We targeted the Rosa26 locus with
a construct containing a strong CAG promoter followed by a
floxed neomycin resistance cassette, a transcriptional stop sig-
nal, and GFP-L10a cDNA (Fig. 1B and Fig. S1A). Incidentally,
the GFP-L10a cDNA was flanked by Frt sequences, allowing its
excision by Flp recombinase and subsequent expression of the
Escherichia coli BirA enzyme, which permits selective bio-
tinylation of appropriately tagged proteins. Cre-activated ex-
pression of BirA from the post-Flp recombined allele will be
described in a subsequent manuscript.
Successful targeting of the Rosa26 locus in murine embryonic
stem (ES) cells yielded Rosa26-flox-stop-TRAP (Rosa26fsTRAP).
Correct homologous recombination was verified by Southern
blotting (Fig. S1B). Cre-mediated recombination in ES cells
yielded constitutively activated TRAP (Rosa26CAG-TRAP), in
which the CAG promoter drives expression of the GFP-L10a
protein (Fig. S1C). To examine the distribution of tagged pro-
tein in ribosomes, we fractionated ES cell lysates on sucrose
gradients (Fig. 1C). As expected, GFP-L10a protein was dis-
tributed primarily in the polysome fraction (fraction 4, con-
taining actively translating transcripts) and the free-ribosome
fraction (fraction 2).
Cre-Mediated, Tissue-Specific Activation of Rosa26fsTRAP in Mice. We
used Rosa26fsTRAP ES cells to generate gene-targeted mice. Con-
sistent with the allele design, we did not detect GFP fluorescence
in the absence of Cre. To evaluate the Cre activation of GFP-
L10a expression in specific cell lineages, we crossed in the TNT-
Cre transgene, which is selectively active in cardiomyocytes. TNT-
Cre activated GFP-L10a expression selectively in the heart (Fig.
S1 D and E), where it was colocalized with the cardiomyocyte
marker TNNI3 (Fig. 1D). GFP-L10a expression was not detected
in epicardial (white arrowheads) or endocardial cells (blue
arrowheads), which are not labeled by TNT-Cre. We confirmed
Cre-dependent expression of GFP-L10a in neonatal heart by
Western blotting (Fig. 1E). GFP-L10a was found only in lysates
of Rosa26fsTRAP hearts that were also positive for the TNT-Cre
transgene. Importantly, TNT-Cre::Rosa26fsTRAP and control
hearts did not differ significantly upon echocardiographic anal-
ysis (Fig. S1F), indicating that the GFP-L10a protein does not
interfere with heart function.
We also globally activated the GFP-L10a expression by ex-
cising the floxed stop cassette in the germ line. The resulting
Rosa26CAG-TRAP mice were viable and fertile as homozygotes.
Homozygotes survived to weaning at the expected Mendelian
frequency [from heterozygous intercrosses, we obtained 25%
Fig. 1. Generation and characterization of a Cre-activated TRAP allele. (A)
TRAP strategy to pull down transcripts bound to GFP-tagged ribosomes. (B)
Structure of targeted Rosa26fsTRAP allele. (C) EGFP-L10a incorporates into
assembled ribosomes and polysomes. Equal volumes of the indicated frac-
tions (1–4) from sucrose gradient polysome fractionation of Rosa26CAG-TRAP
ES cells were assayed for GFP-L10a by Western blot. (D) Section of E12.5 TNT-
Cre::Rosa26fsTRAP heart. TNNI3-positive cardiomyocytes coexpressed GFP. (E)
Western blot showing Cre-dependent expression of GFP-L10a fusion protein
in neonatal Rosa26fsTRAP heart. (F) Germ-line Cre recombination yielded
Rosa26CAG-TRAP mice, which showed widespread GFP-L10a expression.
Fig. 2. Capture of endothelial transcripts from heart with Tie2-TRAP. (A)
Tie2-Cre–activated Rosa26fsTRAP expression in endothelial cells. Boxed area at
Left is magnified at Right. LV, left ventricle. (B) Transcript enrichment by
qRT-PCR in Tie2-TRAP or TNT-TRAP isolated from heart. (C) Heatmap
showing an overview of genes differentially expressed between Tie2-TRAP
and TNT-TRAP of heart RNA by RNA-seq. (D) Histogram of Tie2-TRAP:input
ratios, showing high values (>5) for known endothelial-restricted transcripts.
(E) qRT-PCR measurement of Tie2-TRAP:input ratio in heart RNA of arbi-
trarily selected genes with an RNA-seq ratio greater than 5. Tnnt2 andMyh6
were included as negative controls. (F) Eurexpress high-throughput in situ
hybridization images of selected genes with high Tie2-TRAP:input ratio. The
classic endothelial gene Tek (also known as Tie2) has a typical endothelial/
endocardial staining pattern. Prkd2 and Tspan6 are less-characterized genes
with endothelial-restricted expression identified by high Tie2-TRAP:input
ratios. See also Fig. S2. Data in B and E are displayed as mean ± SEM.
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(11/44) homozygotes], had normal heart function by echocardi-
ography, and lived without overt phenotype or premature demise
for over 8 mo. GFP-L10a was widely expressed, as determined by
observation of robust GFP fluorescence (Fig. 1F) and by im-
munoblotting (Fig. S1G). GFP immunoprecipitation under
conditions that stabilize ribosomes and block translational
elongation (TRAP) pulled down about 40% of total RNA in
heart and brain (heart 42 ± 7%, brain 38 ± 6%, n = 4, P > 0.05).
These data indicate that the CAG promoter drives widespread
GFP-L10a expression and that this is not overtly detrimental to
mouse development or survival, and that the Rosa26fsTRAP allele
will likely be useful for lineage tracing and TRAP analysis in
multiple organs.
TRAP Identification of Endothelial-Enriched Transcripts. TRAP has
been used to measure cell-specific transcriptional profiles from
whole tissues in which the cell population of interest selectively
expresses GFP-L10a (4). To further characterize the Rosa26fsTRAP
allele and to identify transcripts enriched in endothelial and en-
docardial cells, we generated Tie2-Cre::Rosa26fsTRAP mice. The
endothelial cell-specific Tie2-Cre transgene selectively activated
GFP-L10a expression in endothelial cells, as demonstrated by
costaining with the endothelial marker PECAM1 (Fig. 2A). Next,
we used GFP immunoprecipitation under conditions that stabilize
ribosomes and block translational elongation to isolate total
cytoplasmic RNA (input) and GFP-L10a–bound RNA (TRAP)
from Tie2-Cre::Rosa26fsTRAP and TNT-Cre::Rosa26fsTRAP heart.
We refer to the TRAP fraction from Tie2-Cre::Rosa26fsTRAP and
TNT-Cre::Rosa26fsTRAP as “Tie2-TRAP” and “TNT-TRAP,” re-
spectively. Quantitative RT-PCR (qRT-PCR) for canonical
endothelial transcripts Cdh5 (VE-cadherin) and Tek (Tie2)
showed that these transcripts were enriched in Tie2-TRAP by
over 10-fold compared with the housekeeping gene Gapdh,
whereas they were depleted in TNT-TRAP (Fig. 2B). On the
other hand, cardiomyocyte-specific transcripts Myh6 (myosin
heavy chain α) and Tnnt2 (TNT) were depleted in Tie2-TRAP
(Fig. 2B). These cardiomyocyte transcripts were not substantially
enriched by TNT-TRAP, likely because the preponderance of
heart RNA arises from cardiomyocytes, so that TRAP cannot
substantially further enrich the cardiomyocyte-specific transcripts.
Having established that Tie2-TRAP and TNT-TRAP selec-
tively capture endothelial and cardiomyocyte transcripts, we next
evaluated the global gene expression profile of endothelial and
cardiomyocyte cells by RNA-seq (Datasets S1 and S2). There
were 1,524 genes differentially expressed (P < 0.0001) between
Tie2-TRAP and TNT-TRAP in biological duplicate samples
(Fig. 2C). The Tie2-TRAP:input ratio is a measure of endothe-
lial cell enrichment. For instance, the signature endothelial genes
Pecam1, Tie2, Cdh5, and Robo4 all had Tie2-TRAP:input ratios
higher than 5 (Fig. 2D). We randomly selected several additional
transcripts with Tie2-TRAP:input ratios of greater than 5 and
validated the RNA-seq data by qRT-PCR (Fig. 2E). In all 21
genes examined, the endothelium-biased signal found by RNA-
seq was confirmed by qRT-PCR, whereas negative control genes
Tnnt2 and Myh6 had low Tie2-TRAP:input ratios, as expected.
We identified putative endothelial/endocardial cell-enriched
transcripts by Tie2-TRAP:input ratios higher than five and
strong endothelial expression (Tie2-TRAP level > 10 RPKM).
There were 908 genes that matched these criteria (Dataset S2),
including known endothelial cell-specific transcripts Pecam1,
Tie2, Cdh5, and Robo4. From these, we selected 290 genes with
a range of Tie2-TRAP:input ratios and evaluated their expres-
sion pattern in Eurexpress, a public gene expression database
containing high-throughput embryonic day (E)14.5 whole-embryo
in situ hybridization data (9). Of these, sixty-four (47%) were
expressed selectively in endothelial cells or endothelial cells plus
the thymus (Fig. 2F and Fig. S2A), which contains blood cells that
are also labeled by Tie2-Cre. Among these were known endo-
thelial cell transcripts (e.g., Tek and Hdac7), as well as transcripts
with previously less well characterized expression patterns (e.g.,
Prkd2 and Tspan6; Fig. 2F).
Collectively, these data indicate that Cre-activated TRAP and
RNA-seq are unbiased means to interrogate cell type-specific
transcriptomes.
Analysis of Cardiomyocyte Gene Expression. Although many studies
have reported on cardiac gene expression profiling, few have
looked at gene expression selectively in cardiomyocytes from
intact tissue. In part, this is due to the difficulty in obtaining
purified cardiomyocyte populations without lengthy isolation
procedures, which may themselves alter gene expression profiles.
Although cardiomyocytes constitute a large proportion of car-
diac mass and RNA, noncardiomyocytes also contribute to over-
all gene expression profiles. Disease models such as aortic banding
alter cardiomyocyte and nonmyocyte gene expression, as well as
the relative proportion of each cell type. Thus, selective mea-
surement of gene expression in cardiomyocytes might yield dif-
ferent results in disease models compared with whole-heart
expression profiling.
To investigate the usefulness of TNT-TRAP in transcriptional
analysis of differential gene expression in heart disease models,
we performed aortic banding or sham operation of TNT-Cre::
Rosa26fsTRAP mice. We used moderate banding conditions that
Fig. 3. Analysis of differential gene expression using TRAP. (A) Gene ex-
pression was measured 2 wk after aortic banding. Fold change was calcu-
lated from RNA-seq of input and TNT-TRAP (n = 3). Blue, differentially
expressed between band and sham in both input and TRAP RNA. Red, dif-
ferentially expressed between band and sham in either input or TRAP but
not both. Gray, genes that were not differentially expressed in either RNA
fraction. Coding transcripts with RPKM >5 are shown. A subset of genes
selected for qRT-PCR validation is indicated. (B) qRT-PCR validation of RNA-
seq data. Expression of the indicated genes was measured by qRT-PCR. n =
3–6 samples per group. *P < 0.05. NS, not significant. Data are displayed as
mean ± SEM.
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caused substantial hypertrophy without inducing systolic dys-
function 2 wk after the operation (Fig. S3). At these time points,
we isolated total heart cytosolic RNA (input) or RNA bound to
TNT-Cre–activated GFP-L10a (TNT-TRAP) from sham or band
groups. Biological triplicate RNA samples were prepared for
each of the resulting four groups and analyzed by qRT-PCR or
RNA-seq (Datasets S1 and S3). We identified differentially
expressed genes between band and sham (P < 0.05; expression
level over 5 RPKMs in at least one sample) in input and TRAP
samples. There were 521 and 548 genes differentially expressed
between band and sham in input or TRAP fractions, respectively.
Of these, 231 genes were differentially expressed in both input
and TRAP fractions, 290 were changed in input but not TRAP,
and 317 were changed in TRAP but not input (Fig. 3A). We
evaluated 14 genes by qRT-PCR (Fig. 3B and Fig. S3 D and E).
There was overall good correlation between fold change mea-
sured by RNA-seq compared with qRT-PCR (R = 0.9), and
statistical comparisons agreed between RNA-seq and qRT-PCR
in 18 of 25 cases (Fig. S3 D and E). These data indicate that cell
type-selective Cre-activated Rosa26fsTRAP is a useful means to
hone in on differential expression in the cell type of interest,
even in cases where those cells constitute the majority of the
tissue mass. Furthermore, the TRAP fraction constitutes actively
translating RNAs and hence may more closely reflect gene
product function than total RNA.
Translational Regulation of Coding Transcripts. Gene expression is
regulated at the level of transcription and translation, and re-
cent studies have suggested that translational regulation is at
least as important as transcriptional regulation in determining
cellular protein abundance (2). The predominant described use
of TRAP has been to study tissue-specific gene expression. We
tested the hypothesis that TRAP enrichment of ribosome-
bound RNAs would allow it to measure one aspect of trans-
lational regulation, the extent of ribosome loading onto gene
transcripts, herein termed “ribosome occupancy,” a measure
of translational efficiency.
Sucrose gradient sedimentation has been the standard tech-
nique to measure ribosome occupancy. This method was used to
show that in ES cells, actin (Actb) was predominantly associated
with actively translating ribosomes, whereas roughly half of Atf5
and little of the noncoding RNA H19 were found in this fraction
(10). TRAP may be an alternative, more streamlined method to
assess ribosome binding and active translation. To benchmark
TRAP’s effectiveness in measuring a transcript’s ribosome oc-
cupancy, we directly compared the ribosome binding of these
transcripts by TRAP versus sucrose gradient sedimentation
from ES cell lysates. The TRAP and sucrose gradient methods
yielded similar results, in that Actb was predominantly found
in the TRAP fraction, whereas only a minority of Atf5 and
a small fraction of H19 transcripts were present in TRAP RNA
(Fig. S4 A and B).
We further compared TRAP and sucrose gradient sedimen-
tation by using each technique to measure translation of Actb
transcripts when ES cells were cultured with increasing concen-
trations of des-methyl, des-amino-pateamine A (DMDA-PatA),
a potent inhibitor of translational initiation (11). DMDA-PatA
reduced Actb transcript abundance in both polysomal RNA and
TRAP RNA, and relative inhibition measured by TRAP and
sucrose gradient methods paralleled one another (Fig. S4C),
although the sucrose gradient measurement was consistently
shifted toward more potent DMDA-PatA inhibition. Likely this
is because DMDA-PatA blocked polysome formation but left
some monosomes intact (Fig. S4D), and RNA assembled on
tagged monosomes will coprecipitate during the TRAP pro-
cedure. Collectively, these data show that the TRAP procedure
pulls down ribosome-associated RNAs and can be used to assess
mRNA ribosome occupancy.
We next used the Rosa26 TRAP allele to investigate ribosome
binding in tissues in vivo. In a complex tissue, the TRAP:input
ratio is influenced by both GFP-L10a expression pattern and
GFP-L10a ribosome binding. To focus on GFP-tagged ribosome
binding to transcripts and minimize the effect of cell type-
restricted GFP-L10a expression, we used Rosa26CAG-TRAP mice,
in which the constitutively activated GFP-L10a is widely expressed
by the CAG promoter. We generated four sets of RNA-seq data
for sham and banded hearts, collecting heart ventricles 1 d and
2 wk after the operation (Datasets S1 and S4). We initially fo-
cused on coding transcripts, and used the TRAP:input ratio from
Rosa26CAG-TRAP heart as a measure of ribosome occupancy. In
the sham 2-wk sample, 80% of transcripts had CAG-TRAP:input
ratios within an ∼1.4 log2 scale range (2.6-fold linear scale),
suggesting that ribosome binding of most transcripts occurs within
a limited dynamic range (Fig. 4A). The coding transcripts with the
lowest ribosome binding (lowest 500) were enriched for functional
annotations related to actin cytoskeleton organization and regu-
lation of actin filaments [false discovery rate (FDR) = 4.8 × 10−5;
Table 1]. In contrast, transcripts with the highest ribosome
binding (highest 500) were strongly enriched for mitochondria
(FDR = 1.6 × 10−35; Table 1) and oxidative phosphorylation
(FDR = 5.5 × 10−20). Transcripts encoding ribosomal proteins
were also highly overrepresented (FDR = 2.1 × 10−13); interest-
ingly, the overrepresented ribosomal proteins were largely com-
ponents of mitochondrial ribosomes. These overall patterns were
also found in the other three (2-wk band and 1-d band and sham)
datasets (Fig. 4A).
We examined the relationship of ribosome occupancy mea-
sured by TRAP:input and by sucrose gradient sedimentation in
Rosa26CAG-TRAP heart ventricles. We selected 21 genes that
spanned the gamut of TRAP:input values and measured the
Fig. 4. Analysis of ribosome binding using
Rosa26CAG-TRAP. RNA-seq was performed on
Rosa26CAG-TRAP heart 2 wk after sham or band op-
eration. (A) Cumulative probability plot of the
strength of ribosome binding (TRAP:input) for
coding transcripts with RPKM >5 in sham or band.
Most transcripts had TRAP:input ratios within
a narrow range, and the distribution did not change
with banding. (B) Comparison of sucrose gradient
fractionation and TRAP measurement of trans-
lational activity. TRAP:input values are from RNA-
seq, whereas polysome and total RNA measure-
ments are from qRT-PCR and normalized to Gapdh.
The best-fit line is shown. (C) qRT-PCR measure-
ment of TRAP enrichment relative to Gapdh of se-
lected mitochondrial protein transcripts in multiple tissues. These transcripts had high ribosome binding in heart and liver and lower ribosome binding in
kidney and lung. Data are displayed as mean ± SEM.
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fraction that partitioned into the polysome fraction, compared
with GAPDH. Overall, TRAP:input and normalized polysome:
total were moderately correlated (R = 0.78, P < 0.001; Fig. 4B).
Moreover, these data also validated the high ribosome occu-
pancy of mitochondrial proteins (seven out of the seven tested).
Cardiomyocytes are highly enriched for mitochondria. To
determine whether high ribosome occupancy of these transcripts
is ubiquitous or is regulated between different tissues, we used
qRT-PCR to measure TRAP:input ratios for mitochondrial
transcripts Cox5a, Cox6a2, and Cox8b in multiple tissues (Fig.
4C). Interestingly, their TRAP:input ratios varied substantially
between tissues. For instance, Cox5a, encoding a cytochrome c
subunit, showed strong enrichment in TRAP from heart but not
in kidney or lung. Cox6a2 was strongly ribosome-bound in liver
and heart and more weakly ribosome-bound in kidney and lung.
These data indicate that translation of some mitochondrial
transcripts is under strong tissue-specific regulation.
Increased translation has been identified as a hallmark of
cardiac hypertrophy (12), although this has not been studied at
a genome-wide scale. We used RNA-seq and the CAG-TRAP:
input ratio to provide an unbiased assessment of changes in ri-
bosome occupancy that occur following pressure overload. We
found that the overall distribution of the TRAP:input ratio of
coding transcripts was not significantly different in the band
compared with the sham group at 1 d or 2 wk after banding (Fig.
4A), suggesting there is no significant change in overall ribosome
occupancy after banding. Considering protein-coding genes with
altered ribosome binding at 24 h between band and sham, the
top 2.5 percentile (143 genes) was significantly enriched for
genes related to ribosomes and translation, mitochondria, and
sarcomeres (Dataset S4). These sarcomere genes included tro-
pomodulin 1, myotilin, myozenin 2, PDZ, and limb domain 3.
Many Noncoding RNAs Exhibit Significant Ribosome Binding. Un-
biased transcriptional profiling has revealed many noncoding
RNA classes, such as long intergenic noncoding RNAs, antisense
transcripts, and pseudogenes, as well as truncated transcripts
presumably generated by nonsense-mediated decay. The ex-
pression pattern and function of most of noncoding transcripts
remain unknown. Using TRAP, we assayed ribosome binding to
noncoding transcripts, subgrouped by their Ensembl transcript
classification (SI Materials and Methods). Interestingly, the large
majority of annotated noncoding transcripts bind to ribosomes
with a similar distribution as coding transcripts (Fig. 5A). How-
ever, the lincRNA subclass showed a distribution that was sig-
nificantly enriched in low ribosome binding (Fig. 5A). Among
these transcripts were two of the better-characterized noncoding
RNAs, H19 and Neat1 (Fig. 5A; see also Fig. 4B). These data
indicate that a subset of lincRNAs is not significantly bound by
ribosomes, consistent with their presumed function as RNAs
rather than proteins.
Surprisingly, the majority of lincRNAs (∼65%) showed a pro-
file of stronger ribosome binding that was comparable to protein-
coding transcripts (Fig. 5A). We used a coding probability score
(13) to assess whether inaccurate annotation of coding tran-
scripts as noncoding was likely to account for this unexpected
ribosome binding. Among lincRNA transcripts expressed above
threshold, only 10% had a score suggestive of coding potential.
Thus, inaccurate classification of coding transcripts as lincRNAs
is unlikely to account for the unexpectedly high frequency of
substantial ribosome binding. Because ribosome-bound RNAs
isolated by TRAP include both transcripts present in polysomes
and monosomes (Fig. S4C), we performed sucrose density sed-
imentation to further characterize three selected ribosome-
bound RNAs. Two of the three, Snhg1 and Dleu2, were found in
the polysome fraction in the approximate proportion projected
based on the TRAP:input value, whereas Snhg7 was relatively
underrepresented in the polysome fraction relative to the TRAP:
input value (Fig. 4B). These data suggest that a substantial
fraction of lincRNAs is bound by ribosomes, including those
assembled into polysomes.
We evaluated whether or not banding had a significant ef-
fect on ribosome binding of lincRNAs by analyzing RNA-seq
data on the input and TRAP RNAs of sham or band-operated
Rosa26CAG-TRAP mice. The overall distribution of lincRNA
binding to ribosomes did not change significantly with banding
(Fig. S5). We also examined individual lincRNAs for differential
expression in banding. Out of 120 lincRNAs above the expression
threshold, 34 were differentially expressed in input RNA with
nominal P < 0.05 (n = 3), including the better-characterized
lincRNAs Gas5 and Neat1 (Fig. 5B and Dataset S5).
Discussion
The TRAP approach improves expression profiling of whole
tissues by isolating ribosomal RNAs from selected cell types (4).
Our study advances the TRAP approach by providing a generic
allele that can be combined with numerous Cre drivers to make
this technology widely available. Moreover, we show that this
technology can be effectively deployed to study translational
regulation and noncoding RNA binding to ribosomes.
The Cre-activated TRAP allele will be useful to profile the
ribosome-bound transcriptome of selected cell types. Using Tie2-
Cre–activated TRAP, we identified a number of transcripts
enriched in endothelial and endocardial cells. One of these was
Prkd2, encoding a protein kinase that interacts with HDAC7
(14), a regulator of endothelial cell transcription (15). The
Table 1. Gene ontology analysis of genes with high or low
ribosome binding
Term Adjusted P value
Low ribosome binding (bottom 500 ranked by TRAP:input)
Actin binding 8.4 × 10−5
Actin filament-based process 3.7 × 10−3
High ribosome binding (top 500 ranked by TRAP:input)
Mitochondrion 1.6 × 10−35
Oxidative phosphorylation 5.5 × 10−20
Ribonucleoprotein 2.1 × 10−13
Mitochondrial ribosome 2.8 × 10−5
NADH dehydrogenase activity 7.9 × 10−3
Protein targeting 4.3 × 10−2
All functional terms with significant enrichment (Benjamini–Hochberg–
corrected P value < 0.05) for genes with the strongest or weakest ribosome
binding are shown.
Fig. 5. lincRNA ribosome binding. (A) Noncoding RNA ribosome binding
profiles. Cumulative probability plot of ribosome binding strength by dif-
ferent noncoding RNA classes shows that lincRNAs are enriched for weak
ribosome binding. Other noncoding RNA classes share ribosome binding
profiles similar to coding transcripts. (B) Histogram showing that expression
of a subset of lincRNAs changed significantly in input RNA between band
and sham groups 2 wk after the operation. Transcripts with extreme up- or
down-regulation are indicated by name.
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biological significance of enriched expression of Prkd2 and other
endothelium-enriched transcripts identified in this study requires
further investigation.
A known limitation of gene expression profiling of whole tis-
sues is that gene expression changes in disease models may occur
as a result of a change in the proportion of cell types, or in cells
that are not the primary interest of the study. Even when the cell
type of interest constitutes the majority of the tissue mass, cell
type-targeted expression profiling is important to isolate changes
that occur in the cells of interest. We observed this in the heart,
where less than half of the genes that were differentially
expressed between band and sham in the whole heart were also
differentially expressed in cardiomyocyte TRAP RNA. Impor-
tantly, TRAP RNAs are also the actively translated fraction, and
hence might be expected to be more closely related to protein-
coding gene product expression than total RNA.
Regulation of translation is an important mechanism for gene
expression control (2), but genome-wide, unbiased analyses of
translational regulation have been limited. We show that TRAP
is an effective and relatively straightforward means to assess ri-
bosome occupancy, one determinant of translational efficiency.
Using TRAP, we provide genome-wide assessment of ribosome
occupancy in pressure overload. Although studies of selected
transcripts suggested that increased protein synthesis is a hall-
mark of cardiac hypertrophy (12), we did not detect globally
increased transcript binding to ribosomes at 1 d or 2 wk after
banding. However, other factors that we did not measure, such as
total ribosome number and elongation rate, also influence pro-
tein synthesis rate. We also did not directly measure the number
of ribosomes loaded onto transcripts, although TRAP efficiency
is likely to correlate with ribosome loading under the conditions
that we used.
We identified transcripts with relatively low or high ribosome
binding in normal heart. Transcripts with low binding were over-
represented for genes involved in actin binding and cytoskeletal
organization, suggesting that these genes are likely regulated at the
translational level. Interestingly, highly ribosome-bound transcripts
were highly enriched for mitochondrial proteins, and efficient ri-
bosome binding of these mitochondrial transcripts is regulated, as
it differed markedly between tissues.
There is growing interest in the function of noncoding RNAs,
particularly lincRNAs. Whether lincRNAs are substantially
translated into proteins has been debated (16–19). We used
TRAP to show that ∼35% of lincRNAs above expression threshold
showed low ribosome binding. Some of these RNAs, such as Neat1,
localize to cellular compartments where they are inaccessible to
the tagged ribosome (20, 21). Others such as H19 are present in
the cytoplasm (22), but appear to be excluded from ribosomes.
The signals and mechanisms that permit these RNAs to avoid
ribosome binding remain to be elucidated, but may involve their
binding by specific proteins (22). The remaining ∼65% of an-
notated lincRNAs did show ribosome binding comparable to
protein-coding transcripts. This finding is consistent with recently
reported results based on ribosome footprinting (16) and with
prior studies showing ribosome association of individual non-
coding RNAs such as Gas5 (23). The significance of this ribo-
some binding requires further investigation, but one possibility is
that a subset of noncoding RNAs may regulate translation of
other transcripts.
Recently, a complementary approach to isolating RNA from
cells labeled by Cre was reported, in which Cre-activated trans-
genic expression of uracil phosphoribosyltransferase (UPRT)
permits selective RNA labeling by thiouracil (TU tagging) (7). A
strength of the TU-tagging strategy is the enhanced temporal
resolution for active transcription. In contrast, TRAP provides
more information on translational regulation and ribosome binding.
The extent of enrichment of endothelial transcripts by Tie-Cre–
driven TRAP also appeared to be higher than achieved by TU
tagging, potentially due to baseline labeling by thiouracil in UPRT-
negative cells (7).
In conclusion, we have established a Cre-activated Rosa26fsTRAP
mouse line and highlighted areas in which this reagent may enhance
studies of gene expression regulation and disease mechanisms. This
mouse line can be combined with a diverse array of Cre drivers to
provide new insights into gene expression regulation.
Materials and Methods
Animals were used according to protocols approved by the Institutional
Animal Care and Use Committee of Boston Children’s Hospital. Rosa26fsTRAP
mice were generated by homologous recombination in J1 ES cells. Poly(A)
RNA was analyzed by RNA-seq or quantitative RT-PCR. Primer sequences can
be found in Dataset S6. See SI Materials and Methods for details.
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